BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26336914)

  • 1. Importance of Histologic Verification of Positive Positron Emission Tomography/Computed Tomography Findings in the Follow-Up of Patients With Malignant Lymphoma.
    Nakayama H; Aisa Y; Ito C; Shimazaki K; Katsumata Y; Hayashi H; Nakazato T
    Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):753-60. PubMed ID: 26336914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy.
    Cheah CY; Dickinson M; Hofman MS; George A; Ritchie DS; Prince HM; Westerman D; Harrison SJ; Burbury K; Wolf M; Januszewicz H; Herbert KE; Carney DA; Tam C; Seymour JF
    Ann Hematol; 2014 Jul; 93(7):1193-200. PubMed ID: 24595733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental PET/CT findings in the cancer patient: how should they be managed?
    Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
    Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission.
    Truong Q; Shah N; Knestrick M; Curley B; Hu Y; Craig M; Hamadani M
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):50-5. PubMed ID: 24119465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
    Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
    Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
    Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
    Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is contrast material needed after treatment of malignant lymphoma in positron emission tomography/computed tomography?
    Nakamoto Y; Nogami M; Sugihara R; Sugimura K; Senda M; Togashi K
    Ann Nucl Med; 2011 Feb; 25(2):93-9. PubMed ID: 20957527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
    Qiao WL; Zhao JH; Wang C; He ZY; Wang TS; Xing Y
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):536-9. PubMed ID: 18069637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management impact of clinically significant incidental lesions detected on staging FDG PET-CT in patients with non-small cell lung cancer (NSCLC): an analysis of 649 cases.
    Lin M; Ambati C
    Lung Cancer; 2012 Jun; 76(3):344-9. PubMed ID: 22206598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical value of incidental 18F-fluorodeoxyglucose-avid foci detected on positron emission tomography/computed tomography.
    Ozkol V; Alper E; Aydin N; Ozkol HF; Topal NB; Akpinar AT
    Nucl Med Commun; 2010 Feb; 31(2):128-36. PubMed ID: 19858768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer.
    De Wever W; Vankan Y; Stroobants S; Verschakelen J
    Eur Respir J; 2007 May; 29(5):995-1002. PubMed ID: 17331966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
    Kumar R; Hawkins RA; Yeh BM; Wang ZJ
    Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary mucosa-associated lymphoid tissue lymphoma: computed tomography and ¹⁸F fluorodeoxyglucose-positron emission tomography/computed tomography imaging findings and follow-up.
    Zhang WD; Guan YB; Li CX; Huang XB; Zhang FJ
    J Comput Assist Tomogr; 2011; 35(5):608-13. PubMed ID: 21926857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
    Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
    J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma.
    Crocchiolo R; Fallanca F; Giovacchini G; Ferreri AJ; Assanelli A; Verona C; Pescarollo A; Bregni M; Ponzoni M; Gianolli L; Fazio F; Ciceri F
    Ann Hematol; 2009 Dec; 88(12):1229-36. PubMed ID: 19468730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of positron emission tomography/computed tomography in the staging of extranodal natural killer/T-cell lymphoma.
    Fujiwara H; Maeda Y; Nawa Y; Yamakura M; Ennishi D; Miyazaki Y; Shinagawa K; Hara M; Matsue K; Tanimoto M
    Eur J Haematol; 2011 Aug; 87(2):123-9. PubMed ID: 21557776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of unexpected additional primary malignancies with PET/CT.
    Ishimori T; Patel PV; Wahl RL
    J Nucl Med; 2005 May; 46(5):752-7. PubMed ID: 15872346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ¹⁸F-FDG PET/CT and Colorectal Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.
    Marcus C; Marashdeh W; Ahn SJ; Taghipour M; Subramaniam RM
    J Nucl Med; 2015 Jul; 56(7):989-94. PubMed ID: 25952738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of routine surveillance with positron emission tomography/computed tomography in aggressive non-Hodgkin lymphoma in complete remission: status in a single center.
    El-Galaly T; Prakash V; Christiansen I; Madsen J; Johansen P; Boegsted M; Johnsen HE; Bukh A
    Leuk Lymphoma; 2011 Apr; 52(4):597-603. PubMed ID: 21314488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.